Cargando…

A dielectrophoresis-based microfluidic system having double-sided optimized 3D electrodes for label-free cancer cell separation with preserving cell viability

Early detection of circulating tumor cells (CTCs) in a patient's blood is essential to accurate prognosis and effective cancer treatment monitoring. The methods used to detect and separate CTCs should have a high recovery rate and ensure cells viability for post-processing operations, such as c...

Descripción completa

Detalles Bibliográficos
Autores principales: Varmazyari, V., Habibiyan, H., Ghafoorifard, H., Ebrahimi, M., Ghafouri-Fard, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287561/
https://www.ncbi.nlm.nih.gov/pubmed/35840699
http://dx.doi.org/10.1038/s41598-022-16286-0
_version_ 1784748278149021696
author Varmazyari, V.
Habibiyan, H.
Ghafoorifard, H.
Ebrahimi, M.
Ghafouri-Fard, S.
author_facet Varmazyari, V.
Habibiyan, H.
Ghafoorifard, H.
Ebrahimi, M.
Ghafouri-Fard, S.
author_sort Varmazyari, V.
collection PubMed
description Early detection of circulating tumor cells (CTCs) in a patient's blood is essential to accurate prognosis and effective cancer treatment monitoring. The methods used to detect and separate CTCs should have a high recovery rate and ensure cells viability for post-processing operations, such as cell culture and genetic analysis. In this paper, a novel dielectrophoresis (DEP)-based microfluidic system is presented for separating MDA-MB-231 cancer cells from various subtypes of WBCs with the practical cell viability approach. Three configurations for the sidewall electrodes are investigated to evaluate the separation performance. The simulation results based on the finite-element method show that semi-circular electrodes have the best performance with a recovery rate of nearly 95% under the same operational and geometric conditions. In this configuration, the maximum applied electric field (1.11 × 10(5) V/m) to separate MDA-MB-231 is lower than the threshold value for cell electroporation. Also, the Joule heating study in this configuration shows that the cells are not damaged in the fluid temperature gradient (equal to 1 K). We hope that such a complete and step-by-step design is suitable to achieve DEP-based applicable cell separation biochips.
format Online
Article
Text
id pubmed-9287561
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-92875612022-07-17 A dielectrophoresis-based microfluidic system having double-sided optimized 3D electrodes for label-free cancer cell separation with preserving cell viability Varmazyari, V. Habibiyan, H. Ghafoorifard, H. Ebrahimi, M. Ghafouri-Fard, S. Sci Rep Article Early detection of circulating tumor cells (CTCs) in a patient's blood is essential to accurate prognosis and effective cancer treatment monitoring. The methods used to detect and separate CTCs should have a high recovery rate and ensure cells viability for post-processing operations, such as cell culture and genetic analysis. In this paper, a novel dielectrophoresis (DEP)-based microfluidic system is presented for separating MDA-MB-231 cancer cells from various subtypes of WBCs with the practical cell viability approach. Three configurations for the sidewall electrodes are investigated to evaluate the separation performance. The simulation results based on the finite-element method show that semi-circular electrodes have the best performance with a recovery rate of nearly 95% under the same operational and geometric conditions. In this configuration, the maximum applied electric field (1.11 × 10(5) V/m) to separate MDA-MB-231 is lower than the threshold value for cell electroporation. Also, the Joule heating study in this configuration shows that the cells are not damaged in the fluid temperature gradient (equal to 1 K). We hope that such a complete and step-by-step design is suitable to achieve DEP-based applicable cell separation biochips. Nature Publishing Group UK 2022-07-15 /pmc/articles/PMC9287561/ /pubmed/35840699 http://dx.doi.org/10.1038/s41598-022-16286-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Varmazyari, V.
Habibiyan, H.
Ghafoorifard, H.
Ebrahimi, M.
Ghafouri-Fard, S.
A dielectrophoresis-based microfluidic system having double-sided optimized 3D electrodes for label-free cancer cell separation with preserving cell viability
title A dielectrophoresis-based microfluidic system having double-sided optimized 3D electrodes for label-free cancer cell separation with preserving cell viability
title_full A dielectrophoresis-based microfluidic system having double-sided optimized 3D electrodes for label-free cancer cell separation with preserving cell viability
title_fullStr A dielectrophoresis-based microfluidic system having double-sided optimized 3D electrodes for label-free cancer cell separation with preserving cell viability
title_full_unstemmed A dielectrophoresis-based microfluidic system having double-sided optimized 3D electrodes for label-free cancer cell separation with preserving cell viability
title_short A dielectrophoresis-based microfluidic system having double-sided optimized 3D electrodes for label-free cancer cell separation with preserving cell viability
title_sort dielectrophoresis-based microfluidic system having double-sided optimized 3d electrodes for label-free cancer cell separation with preserving cell viability
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287561/
https://www.ncbi.nlm.nih.gov/pubmed/35840699
http://dx.doi.org/10.1038/s41598-022-16286-0
work_keys_str_mv AT varmazyariv adielectrophoresisbasedmicrofluidicsystemhavingdoublesidedoptimized3delectrodesforlabelfreecancercellseparationwithpreservingcellviability
AT habibiyanh adielectrophoresisbasedmicrofluidicsystemhavingdoublesidedoptimized3delectrodesforlabelfreecancercellseparationwithpreservingcellviability
AT ghafoorifardh adielectrophoresisbasedmicrofluidicsystemhavingdoublesidedoptimized3delectrodesforlabelfreecancercellseparationwithpreservingcellviability
AT ebrahimim adielectrophoresisbasedmicrofluidicsystemhavingdoublesidedoptimized3delectrodesforlabelfreecancercellseparationwithpreservingcellviability
AT ghafourifards adielectrophoresisbasedmicrofluidicsystemhavingdoublesidedoptimized3delectrodesforlabelfreecancercellseparationwithpreservingcellviability
AT varmazyariv dielectrophoresisbasedmicrofluidicsystemhavingdoublesidedoptimized3delectrodesforlabelfreecancercellseparationwithpreservingcellviability
AT habibiyanh dielectrophoresisbasedmicrofluidicsystemhavingdoublesidedoptimized3delectrodesforlabelfreecancercellseparationwithpreservingcellviability
AT ghafoorifardh dielectrophoresisbasedmicrofluidicsystemhavingdoublesidedoptimized3delectrodesforlabelfreecancercellseparationwithpreservingcellviability
AT ebrahimim dielectrophoresisbasedmicrofluidicsystemhavingdoublesidedoptimized3delectrodesforlabelfreecancercellseparationwithpreservingcellviability
AT ghafourifards dielectrophoresisbasedmicrofluidicsystemhavingdoublesidedoptimized3delectrodesforlabelfreecancercellseparationwithpreservingcellviability